Scholarlink

<p>The management of brain abscesses, particularly with <i>Escherichia coli</i> (<i>E. coli</i>) in immunocompromised patients, remains contentious. This study evaluates the bioactive potential of <i>Ficus benghalensis</i> extracts against brain abscess pathogens, including multidrug-resistant <i>E. coli</i> and <i>Staphylococcus aureus (S. aureus)</i>, through phytochemical, pharmacological, and computational analyses. High yields (75–85%) were obtained from polar solvent extraction (acetone, methanol, ethyl acetate). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) identified 30 bioactive compounds, including myricetin, naringenin-7-O-rutinoside, and harpagoside. Methanol extracts exhibited potent antimicrobial activity with inhibition zones of 18.2 mm (<i>E. coli</i>) and 17.9 mm (<i>S. aureus</i>) and minimum inhibitory concentration (MIC) values of 210–250 µg/mL. Ex vivo assays on clinical isolates showed dose-dependent inhibition (MIC50 = 150 µg/mL). Molecular docking indicated quercetin (−7.5 kcal/mol) and kaempferol (−7.8 kcal/mol) targeting <i>E. coli</i> FimH and OmpA, while lupeol (−9.1 kcal/mol) and ellagic acid (−8.7 kcal/mol) targeted <i>S. aureus</i> PBP2a and Hla. Pharmacokinetic analysis revealed quercetin and gallic acid as lead candidates with 100% gastrointestinal (GI) absorption and bioavailability (0.55–0.56), but limited blood-brain barrier (BBB) permeability (brain score: 0.24). Three-dimensional quantitative structure-activity relationship (3D-QSAR) comparative molecular field analysis (CoMFA) models (R<sup>2</sup> = 0.111, Q<sup>2</sup> = 0.00) emphasized steric and electrostatic interactions (84%) in bioactivity. These findings suggest that <i>Ficus benghalensis</i> holds potential as a multitarget antimicrobial agent for brain abscess therapy, with further optimization for central nervous system (CNS) delivery needed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In Silico and In Vitro Analysis of Bioactive Compounds from Ficus benghalensis as a Novel Approach to Targeting Brain Abscess Pathogen

  • 期刊论文

  • 发表日期：

    2025年7月17日

查看全文
  • Ihtesham Arshad,
  • Maryum Zainab,
  • Ayesha Farooq,
  • Saira Zulfiqar,
  • Anna Ali,
  • Rubina Bibi,
  • Shaista Shafiq,
  • Imran Zafar,
  • Muhammad Mazhar Ayaz,
  • Yahya A. Almutawif,
  • Najeeb Ullah Khan

摘要

The management of brain abscesses, particularly with Escherichia coli (E. coli) in immunocompromised patients, remains contentious. This study evaluates the bioactive potential of Ficus benghalensis extracts against brain abscess pathogens, including multidrug-resistant E. coli and Staphylococcus aureus (S. aureus), through phytochemical, pharmacological, and computational analyses. High yields (75–85%) were obtained from polar solvent extraction (acetone, methanol, ethyl acetate). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) identified 30 bioactive compounds, including myricetin, naringenin-7-O-rutinoside, and harpagoside. Methanol extracts exhibited potent antimicrobial activity with inhibition zones of 18.2 mm (E. coli) and 17.9 mm (S. aureus) and minimum inhibitory concentration (MIC) values of 210–250 µg/mL. Ex vivo assays on clinical isolates showed dose-dependent inhibition (MIC50 = 150 µg/mL). Molecular docking indicated quercetin (−7.5 kcal/mol) and kaempferol (−7.8 kcal/mol) targeting E. coli FimH and OmpA, while lupeol (−9.1 kcal/mol) and ellagic acid (−8.7 kcal/mol) targeted S. aureus PBP2a and Hla. Pharmacokinetic analysis revealed quercetin and gallic acid as lead candidates with 100% gastrointestinal (GI) absorption and bioavailability (0.55–0.56), but limited blood-brain barrier (BBB) permeability (brain score: 0.24). Three-dimensional quantitative structure-activity relationship (3D-QSAR) comparative molecular field analysis (CoMFA) models (R2 = 0.111, Q2 = 0.00) emphasized steric and electrostatic interactions (84%) in bioactivity. These findings suggest that Ficus benghalensis holds potential as a multitarget antimicrobial agent for brain abscess therapy, with further optimization for central nervous system (CNS) delivery needed.